186 related articles for article (PubMed ID: 12422138)
21. Esmolol, the first ultra-short-acting intravenous beta blocker for use in critically ill patients.
Blanski L; Lutz J; Laddu A
Heart Lung; 1988 Jan; 17(1):80-9. PubMed ID: 3276651
[TBL] [Abstract][Full Text] [Related]
22. Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent.
Angaran DM; Schultz NJ; Tschida VH
Clin Pharm; 1986 Apr; 5(4):288-303. PubMed ID: 2871961
[TBL] [Abstract][Full Text] [Related]
23. The use of esmolol in whole-body hyperthermia: cardiovascular effects.
Berry JM; Michalsen A; Nagle V; Bull JM
Int J Hyperthermia; 1997; 13(3):261-8. PubMed ID: 9222810
[TBL] [Abstract][Full Text] [Related]
24. Symptomatic and hemodynamic recovery following dobutamine stress echo: benefit of low-dose esmolol administration.
Abdullah EE; Pollick C
Int J Card Imaging; 1997 Feb; 13(1):53-7. PubMed ID: 9080239
[TBL] [Abstract][Full Text] [Related]
25. Esmolol is noninferior to metoprolol in achieving a target heart rate of 65 beats/min in patients referred to coronary CT angiography: a randomized controlled clinical trial.
Maurovich-Horvat P; Károlyi M; Horváth T; Szilveszter B; Bartykowszki A; Jermendy ÁL; Panajotu A; Celeng C; Suhai FI; Major GP; Csobay-Novák C; Hüttl K; Merkely B
J Cardiovasc Comput Tomogr; 2015; 9(2):139-45. PubMed ID: 25819196
[TBL] [Abstract][Full Text] [Related]
26. A randomised study of perioperative esmolol infusion for haemodynamic stability during major vascular surgery; rationale and design of DECREASE-XIII.
Bakker EJ; Ravensbergen NJ; Voute MT; Hoeks SE; Chonchol M; Klimek M; Poldermans D
Eur J Vasc Endovasc Surg; 2011 Sep; 42(3):317-23. PubMed ID: 21632265
[TBL] [Abstract][Full Text] [Related]
27. Failure of adjuvant heparin to reduce myocardial ischemia in the early treatment of patients with unstable angina.
Wallis DE; Boden WE; Califf R; Crawford MH; Hakki AH; Iskandrian AS; Labovitz A; O'Connor C; Sutton R; Scanlon PJ
Am Heart J; 1991 Oct; 122(4 Pt 1):949-54. PubMed ID: 1681722
[TBL] [Abstract][Full Text] [Related]
28. Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemia.
Kirshenbaum JM; Kloner RA; Antman EM; Braunwald E
Circulation; 1985 Oct; 72(4):873-80. PubMed ID: 2863013
[TBL] [Abstract][Full Text] [Related]
29. Effects of early treatment with captopril and metoprolol singly or together on six-month mortality and morbidity after acute myocardial infarction. Results of the RIMA (Rimodellamento Infarto Miocardico Acuto) study. The RIMA researchers.
Coletta C; Ricci R; Ceci V; Seccareccia F; Rulli F; Mazzuca V; Putini RL; Salustri A; Bottero G; Pasquale M
G Ital Cardiol; 1999 Feb; 29(2):115-24; discussion 125-9. PubMed ID: 10088066
[TBL] [Abstract][Full Text] [Related]
30. Clinical pharmacokinetics and therapeutic efficacy of esmolol.
Wiest DB; Haney JS
Clin Pharmacokinet; 2012 Jun; 51(6):347-56. PubMed ID: 22515557
[TBL] [Abstract][Full Text] [Related]
31. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
Bessho R; Chambers DJ
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
[TBL] [Abstract][Full Text] [Related]
32. Esmolol: a short-acting titratable beta-blocker in acute myocardial ischemia.
Viray R; Turlapaty P; Laddu A
Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):153-61. PubMed ID: 2900818
[TBL] [Abstract][Full Text] [Related]
33. Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia.
Kloner RA; Kirshenbaum J; Lange R; Antman EM; Braunwald E
Am J Cardiol; 1985 Oct; 56(11):40F-48F. PubMed ID: 2864848
[TBL] [Abstract][Full Text] [Related]
34. Esmolol and percutaneous cardiopulmonary bypass enhance myocardial salvage during ischemia in a dog model.
Laub GW; Muralidharan S; Reibman J; Fernandez J; Anderson WA; Gu J; Daloisio C; McGrath LB; Mulligan LJ
J Thorac Cardiovasc Surg; 1996 May; 111(5):1085-91. PubMed ID: 8622306
[TBL] [Abstract][Full Text] [Related]
35. Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction.
Halkin A; Grines CL; Cox DA; Garcia E; Mehran R; Tcheng JE; Griffin JJ; Guagliumi G; Brodie B; Turco M; Rutherford BD; Aymong E; Lansky AJ; Stone GW
J Am Coll Cardiol; 2004 May; 43(10):1780-7. PubMed ID: 15145099
[TBL] [Abstract][Full Text] [Related]
36. [Atenolol i.v. in the acute phase of AMI: the indications, contraindications and interactions with thrombolytic drugs in the GISSI-2 study. The GISSI-2 Researchers. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
Mafrici A; Mauri F; Maggioni AP; Franzosi MG; Santoro L; De Vita C
G Ital Cardiol; 1995 Mar; 25(3):353-64. PubMed ID: 7642042
[TBL] [Abstract][Full Text] [Related]
37. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery.
Raby KE; Brull SJ; Timimi F; Akhtar S; Rosenbaum S; Naimi C; Whittemore AD
Anesth Analg; 1999 Mar; 88(3):477-82. PubMed ID: 10071990
[TBL] [Abstract][Full Text] [Related]
38. Esmolol versus diltiazem in atrial fibrillation following coronary artery bypass graft surgery.
Hilleman DE; Reyes AP; Mooss AN; Packard KA
Curr Med Res Opin; 2003; 19(5):376-82. PubMed ID: 13678474
[TBL] [Abstract][Full Text] [Related]
39. [The use of a beta-blocker esmolol in patients with acute myocardial infarction treated with streptokinase].
Shalaev SV; Bukhvalov VA; Petrik ES; Shabalkov EA
Kardiologiia; 2002; 42(6):4-7. PubMed ID: 12494123
[TBL] [Abstract][Full Text] [Related]
40. [The hemodynamic effects of a treatment with beta-receptor blockers during coronary surgery. A comparison between acebutolol and esmolol].
Kling D; Boldt J; Zickmann B; Dapper F; Hempelmann G
Anaesthesist; 1990 May; 39(5):264-8. PubMed ID: 1972611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
